Your session is about to expire
← Back to Search
Group MDMA Therapy for PTSD (Group-MVP Trial)
Group-MVP Trial Summary
This trial assesses the feasibility & safety of MDMA-assisted group therapy for PTSD in veterans. Up to 18 participants will receive therapy sessions in 3 cohorts.
Group-MVP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Group-MVP Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research study provide the opportunity for seniors to participate?
"The minimum age for enrollment in this medical trial is 18 years old, while the maximum acceptable age of participation is 64."
Is participation in this study open to qualified individuals at the present time?
"Affirmative. Information on clinicaltrials.gov testifies that this trial is still recruiting subjects; it was initially posted on October 1st 2023 and revised most recently on October 2nd of the same year. 18 participants are necessary from one medical centre to complete the study requirements."
How many individuals may partake in this investigation?
"Affirmative. According to clinicaltrials.gov, this research is currently recruiting participants and was initially posted on October 1st 2023. The most recent edit occurred on the 2nd of October in that same year. 18 individuals must be sourced from a single site for this experiment to go ahead."
How can I join this clinical experiment?
"This medical experiment requires 18 participants between the ages of majority and 64 with post-traumatic stress disorder, who meet a variety of criteria. These include being veterans in the United States Military, possessing fluency in the language used at their study site, avowing to take medication as per instructions and attend all therapy sessions, agreeing for visits to be recorded including MDMA usage if applicable, nominating an individual that can reach them should they become unreachable or suicidal, informing investigators within 48 hours about any new illnesses or procedures undertaken by them and undergoing pregnancy tests before each experimental session. Additionally women must commit to using contraception during 10 days following the last experimental session"
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger